One email a week. One myth, one advancement, every source.
And when Batool Pharmaceuticals eventually formulates its own products, this list hears first — but that is a later chapter, not the pitch.
The week's fact-check
One claim, taken apart properly, with the verdict and the evidence grade stated up front.
What moved in the pipeline
Readouts, approvals and withdrawals that actually matter, with the development stage attached.
The sources, always
Direct links to every paper referenced, so you can disagree with me from an informed position.
One myth dismantled, one advancement explained. Every Thursday.
No drip funnels, no engagement bait. The week’s fact-check, what changed in the pipeline, and the sources for both — so you can check my work.
Unsubscribe any time. Your address is never sold or shared.
You will get one confirmation email, then the weekly issue. Nothing else, ever. Your address is stored only to send that email, is never sold or shared, and one click unsubscribes you permanently. Privacy policy.